The pharmaceutical company announced today that it is closing its flagship pharmaceuticals plant in Kalvistas, Arizona, due to low operating revenue.
The company said that it will close its flagship Kalvis PCCP plant in April 2020.
“The decision to close the facility is due to the significant impact of the recent economic downturn on our operations,” Adamis CEO Daniel Adams said in a statement.
“We remain committed to our community, and will be working with our employees, partners and stakeholders to provide a sustainable business in the future.
Adamis is a leader in the global pharmaceuticals industry and has a strong focus on improving patient outcomes.
I know our community will be greatly missed by the many people who worked there over the last 25 years.”
The company is in discussions with Kalvís PCCPP to secure additional funding to continue operations at the plant.
Kalvís current employees are being offered positions at other companies.